Mexico ranks among the world’s ten largest exporters of medical devices, yet the pedicle screw that goes into a Mexican patient almost always comes from the United States or Europe. That gap goes a long way toward explaining a mid-sized market shaped, above all, by public procurement.
Mexico’s market for spinal implants and vertebral compression fracture (VCF) treatment was estimaded by more than $135 million in 2023. It expects 6.1% annual growth, which would take the market past $205 million by 2030. For scale, IMARC values Mexico’s entire orthopedic implant market at $873.5 million in 2025. That would make spine about 15% of the total, although the two figures come from different firms and different years. Demand rests on an aging population, more degenerative spine disease and a middle class that is spending more on private care.
ZimVie, now Highridge Medical, led the market in 2023, with strong positions in cervical and thoracolumbar fixation and in interbody cages. Medtronic is second and leads in vertebral compression fractures on the strength of kyphoplasty. DePuy Synthes ranks third and does best in interbody devices. Behind them come Globus Medical+Nuvasive, Orthofix, the German companies Ulrich Medical and SIGNUS, and, in endoscopy, Karl Storz, Richard Wolf and Joimax.
Nearly all of it is imported. Mexico brought in $11.4 billion in medical devices and in vitro diagnostics in 2024, half of it from the United States.
The plants in Tijuana and Chihuahua build product for export under multinational brands, and spinal implants designed in Mexico remain a sliver of the market. The most established local name are:
- Nüva Surgery, whose own Spine Fix brand runs from occipitocervical fixation to kyphoplasty, are Mexico-based companies that work only in spine.
- TDI (Tecnología y Diseño Industrial) in Guadalajara, which has designed and manufactured orthopedic and trauma implants since 2000 under a “Made in Mexico” label and lists a spine line.
- Vel Spine, founded in Mexico City in 2018
The rest of the market belongs to distributors of foreign brands, a growing number of them Indian or Chinese, such as GPC Medical and Auxein.
What sets Mexico apart?
- Public hospitals often buy a service rather than a product. IMSS and IMSS-Bienestar frequently tender an “osteosynthesis and endoprosthesis service,” under which the supplier provides the implants, lends the instrument sets and sends technical staff into the operating room.
- Prices are capped. Consolidated purchasing sets ceilings that hold back the more expensive minimally invasive implants, and artificial discs never displaced fusion because payers would not cover them.
- Care revolves around the hospital. Mexico does less outpatient surgery than other Latin American countries, which slows the uptake of newer techniques.
- Counterfeits are a live issue. In 2023 the health regulator, Cofepris, warned about fake screws, rods, hooks and interbody cages bearing a German brand’s label and no sanitary registration.
- The rules are also changing. The new Universal Health System is pushing the industry to rethink how it will sell to, and supply, the public network.
###
Legal Disclaimer:
Content published on SPINEMarketGroup (thespinemarketgroup.com) is provided for informational purposes only and on an “as is” basis, without warranties of any kind. We do not guarantee the accuracy, completeness, legality, or reliability of any information, images, videos, links, or third-party materials featured on the site. Any views or claims expressed in contributed content or press releases belong to their respective authors or sources. For copyright concerns, factual corrections, or content-related complaints, please contact us directly for review.
